ANZEMET Drug Patent Profile

« Back to Dashboard

Which patents cover Anzemet, and what generic alternatives are available?

Anzemet is a drug marketed by Validus Pharms and is included in two NDAs.

The generic ingredient in ANZEMET is dolasetron mesylate. There is one drug master file entry for this compound. Additional details are available on the dolasetron mesylate profile page.

Summary for ANZEMET

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	4
Patent Applications:	4,877
Drug Prices:	Drug price information for ANZEMET
What excipients (inactive ingredients) are in ANZEMET?	ANZEMET excipients list
DailyMed Link:	ANZEMET at DailyMed

See drug prices for ANZEMET

Recent Clinical Trials for ANZEMET

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Pittsburgh	Phase 2
David A. Clump, MD, PhD	Phase 2
University of Southern California	N/A

See all ANZEMET clinical trials

US Patents and Regulatory Information for ANZEMET

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Validus Pharms	ANZEMET	dolasetron mesylate	INJECTABLE;INJECTION	020624-002	Sep 11, 1997		DISCN	Yes	No
Validus Pharms	ANZEMET	dolasetron mesylate	TABLET;ORAL	020623-001	Sep 11, 1997		DISCN	Yes	No
Validus Pharms	ANZEMET	dolasetron mesylate	INJECTABLE;INJECTION	020624-001	Sep 11, 1997		DISCN	Yes	No
Validus Pharms	ANZEMET	dolasetron mesylate	INJECTABLE;INJECTION	020624-003	Dec 11, 2001		DISCN	No	No

Expired US Patents for ANZEMET

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Validus Pharms	ANZEMET	dolasetron mesylate	TABLET;ORAL	020623-002	Sep 11, 1997	4,906,775
Validus Pharms	ANZEMET	dolasetron mesylate	INJECTABLE;INJECTION	020624-002	Sep 11, 1997	4,906,755
Validus Pharms	ANZEMET	dolasetron mesylate	INJECTABLE;INJECTION	020624-003	Dec 11, 2001	4,906,755
Validus Pharms	ANZEMET	dolasetron mesylate	TABLET;ORAL	020623-002	Sep 11, 1997	4,906,755

International Patents for ANZEMET

See the table below for patents covering ANZEMET around the world.

Country	Patent Number	Title	Estimated Expiration
Argentina	246264	PROCEDIMIENTO PARA PREPARAR ESTERES CARBOCICLICOS DE HEXAHIDRO-8-HIDROXI-2,6-METANO-2H-QUINOLIZIN-3(4H)-ONA. (ESTERS OF HEXADYDRO-8-HYDROXY-2,6-METHANO-2H-QUINOLIZIN-3(4H)-ONE AND RELATED COMPOUNDS)
Argentina	246970	UN PROCEDIMIENTO PARA PREPARAR ESTERES DE HEXAHIDRO-8-HIDROXI-2,6-METANO-2H-QUINOZILIN-(4H)-ONA Y COMPUESTOS RELACIONADOS. (USE OF QUINOLIZINE AND QUINOLIZINONE DERIVATIVES IN THE MANUFACTURE OF MEDICAMENTS)
Austria	109779
Austria	129153

Supplementary Protection Certificates for ANZEMET

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0266730	SPC/GB97/005	United Kingdom		PRODUCT NAME: DOLASETRON, OR A PHARMACEUTICALLY-ACCEPTABLE ACID ADDITION OR QUATERNARY AMMONIUM SALT THEREOF; REGISTERED: UK 04425/0150 19960926
0266730	98C0014	Belgium		PRODUCT NAME: MIGLITOL; NAT. REGISTRATION NO/DATE: NL 22 138 19970204; FIRST REGISTRATION: NL - 19 343 UR 19960723
0266730	C970043	Netherlands		PRODUCT NAME: DOLASETRON, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZUURADDITIEZOUT, IN HET BIJZONDER HET MESYLAAT; NAT REGISTRATION NO/DATE: RVG 21707 - RVG 21709 19970623; FIRST REGISTRATION: GB PL 04425/0150, PL 04425/0152, PL 04425/0154 19960926
0266730	73/1997	Austria		PRODUCT NAME: ANZEMET; NAT. REGISTRATION NO/DATE: 1-22014, 1-22015, 1-22016 19970624; FIRST REGISTRATION: GB PL 04425/0150 19960926